Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

PanTarg secures €1.3 million from BioInnovation Institute to advance its antibody-based cancer treatment technology.

PRIVATESep 08, 2026•about 6 hours ago

Amount Raised

€1.3 Million

Round Type

Seed

CopenhagenBiotechnologyHealth CareLife Science

Investors

Bio Innovation Institute

Description

BioInnovation Institute has allocated €7.8 million in additional funding to support six companies, including PanTarg. Each company will receive €1.3 million to bring their technologies closer to market. PanTarg focuses on an innovative cancer treatment targeting aggressive cancers. This funding follows an earlier investment of €500,000 from BII, bringing PanTarg's total funding to €1.8 million.

Company Information

Company

PanTarg

Location

Copenhagen, Capital Region Of Denmark, Denmark

About

BioInnovation Institute (BII) supports early-stage life science companies and research projects, focusing on human health, biotechnology, and planetary health. They provide funding and resources to help companies advance technologies towards commercialization. BII offers access to an innovation platform, including laboratory facilities and a network of investors and advisors.

Don't miss PanTarg's next move

Get an email the moment PanTarg raises, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Predictive Intelligence
Strategic

ML-powered predictions for PanTarg's next move

See what Strategic adds

Funding Insights

Based on industry data
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

PanTarg raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.